Al-Azayzih A,Al-Qerem W,Al-Azzam S,Muflih S,AlHusein BA,Kharaba Z,Kanaan RJ,Rahhal D .2024 .Prevalence of medication associated with QTc prolongation used among critically Ill patients. Vasc. Health Risk Manag., 20 : 27-37.
Andršová I,Hnatkova K,Šišáková M,Toman O,Smetana P,Huster KM,Barthel P,Novotný T,Schmidt G,Malik M .2021 .Influence of heart rate correction formulas on QTc interval stability. Sci. Rep, 11(1) : 14269.
Dogan A,Tunc E,Varol E,Ozaydin M,Ozturk M M .2005 .Comparison of the four formulas of adjusting QT interval for the heart rate in the middle-aged healthy Turkish men. , 10(2) : 134-141.
Farzanegan B,Hosseinpoor Z,Baniasadi S,Seyyedi SR,Rajabi M .2020 .An observational study of QTc prolongation in critically ill patients: Identification of incidence and predictors. Indian J. Crit. Care Med, 24(4) : 270-275.
Fernandes FM,da Silva Paulino AM,Sedda BC,da Silva EP,Martins RR,Oliveira AG .2019 .Assessment of the risk of QT-interval prolongation associated with potential drug-drug interactions in patients admitted to Intensive Care Units. , 27(2) : 229-234.
Fernandes FM,Silva EP,Martins RR,Oliveira AG .2018 .QTc interval prolongation in critically ill patients: Prevalence, risk factors and associated medications. PloS One, 13(6) : 1-12.
Gervasi SF,Bianco M,Palmieri V,Cuccaro F,Zeppilli P F .2017 .QTc interval in adolescents and young athletes: influence of correction formulas. Int. J. Sports Med, 38(10) : 729-734.
Harb K,Schwartz S,Cooper J .2024 .Pharmacist reported protocols for QTc monitoring of psychiatric medications. J. Cureus., 16(3) : 1-8.
Humza AU,Akbar MA,Bilal Awan MA,Yousuf JB,Khan K,Ammar A .2024 .Prevalence and comparative analysis of potential drug-drug interactions among hospitalized patients at a tertiary care cardiac institute in Pakistan: Findings from a single centre. Pak. J. Pharm. Sci., 37(5) : 961-968.
Humza AU,Hameed A,Akbar MA,Ahmed I,Ali A,Yousuf JB .2024 .Evaluation of medication use and polypharmacy in postoperative cardiac patients: The clinical pharmacist's imperative in a public institute of Pakistan. Pak. J. Pharm. Sci, 37(1) : 17-23.
Humza AU,Siddiq A,Baig SG,Ali A,Ahmed I,Yousuf JB .2024 .Assessment of QTc-interval prolonging medication utilization and associated potential drug-drug interactions in hospitalized cardiac patients: A cross-sectional study in cardiology. Jordan J. Pharm. Sci., 17(3) : 603-610.
Kheshti R,Aalipour M,Namazi S M .2016 .A comparison of five common drug-drug interaction software programs regarding accuracy and comprehensiveness. J. Res. Pharm. Pract, 5(4) : 257-263.
Lima B,Razmjouei S,Bajwa MT,Shahzad Z,Shoewu OA,Ijaz O,Mange P,Khanal S,Gebregiorgis T .2023 .Polypharmacy, gender disparities and ethnic and racial predispositions in long QT syndrome: An in-depth review. Cureus., 15(9) : 1-22.
Neto NRDO,De Oliveira WS,Pinto GDC,De Oliveira ESR,Maria das Neves D ESR .2020 .A practical method for QTc interval measurement. Cureus, 12(12) : 1-7.
Newell B,Wirick N,Rigelsky F,Migal K F .2021 .Implementation of a Pharmacist Monitoring Process for Patients on QTc Prolonging Antibiotics: A Pilot Study. , 56(6) : 772-776.
Rossi M,Marzi F,Natale M,Porceddu A,Tuccori M,Lazzerini PE,Laghi-Pasini F,Capecchi PL .2021 .Drug-associated QTc prolongation in geriatric hospitalized patients: A cross-sectional study in internal medicine. Drugs-real world outcomes.,, 8 : 325-335.
Simon ST,Lin M,Trinkley KE,Aleong R,Rafaels N,Crooks KR,Reiter MJ,Gignoux CR,Rosenberg MA .2024 .A polygenic risk score for the QT interval is an independent predictor of drug-induced QT prolongation. PloS One, 19(6) : 1-15.
Skullbacka S,Airaksinen M,Puustinen J,Toivo T .2022 .Risk assessment tools for QT prolonging pharmacotherapy in older adults: A systematic review. Eur. J. Clin. Pharmacol, 78(5) : 765-779.
Steinbrech J,Amann U,Irlbeck M,Clauß S,Strobach D S .2025 .Risk stratification of QTc prolongations in hospitalized cardiology and gastroenterology patients using the tisdale score-a retrospective analysis. J. Clin. Med, 14(2) : 339.
Su K,McGloin R,Gellatly RM .2020 .Predictive validity of a QTc interval prolongation risk score in the intensive care unit. Pharmacotherapy: J. Hum. Pharmacol. Drug Ther, 40(6) : 492-499.
Tisdale JE,Jaynes HA,Kingery JR,Mourad NA,Trujillo TN,Overholser BR,Kovacs RJ,Outcomes RJ .2013 .Development and validation of a risk score to predict QT interval prolongation in hospitalized patients. Circ. Cardiovasc. Qual., 6(4) : 479-487.
Vandenberk B,Vandael E,Robyns T,Vandenberghe J,Garweg C,Foulon V,Ector J,Willems R,Am R .2016 .Which QT correction formulae to use for QT monitoring. , 5(6) : 1-10.
Wang H,Shi H,Wang N,Wang Y,Zhang L,Zhao Y,Xie J .2022 .Prevalence of potential drug- drug interactions in the cardiothoracic intensive care unit patients in a Chinese tertiary care teaching hospital. BMC Pharmacol, 23(1) : 39.
Woosley RG T,Woosley D,Romero KA,Tucson KA,AZCERT KA .2023 .. QTdrugs list, : .
Yazdanpanah MH,Naghizadeh MM,Sayyadipoor S,Farjam M .2022 .The best QT correction formula in a non-hospitalized population: The Fasa PERSIAN cohort study. BMC Cardiovas, 22(1) : 1-12.